Enzyme inhibitory antibody to pyruvate dehydrogenase: Diagnostic utility in primary biliary cirrhosis

Annals of Clinical Biochemistry

Volumn 37, Issue 1, 2000, Pages 67-73

  Jois, Jennifer ^a   Omagari, Katsuhisa ^b   Rowley, Merrill J ^a   Anderson, John ^a   Mackay, Ian R ^a  

^a MONASH UNIVERSITY   (Australia)

^b NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 OXOACID DEHYDROGENASE; AUTOANTIBODY; PYRUVATE DEHYDROGENASE COMPLEX;

ANALYTIC METHOD; ARTICLE; COLORIMETRY; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; IMMUNOASSAY; IMMUNOFLUORESCENCE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MASS SCREENING; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL;

EID: 0033963610     PISSN: 00045632     EISSN: None     Source Type: Journal    
DOI: 10.1258/0004563001901542     Document Type: Article

References (33)

1. 1 Berg PA, Klein R, Lindenborn-Fotinos J. Anti-mitochondrial antibodies in primary biliary cirrhosis. J Hepatol 1986; 2: 123-31
2. 2 Mouritsen S, Demant E, Permin H, Wiik A. High prevalence of anti-mitochondrial antibodies among patients with some well-defined connective tissue diseases. Clin Exp Immunol 1986; 66: 68-76
3. 3 Sherlock S, Scheuer PJ. The presentation and diagnosis of 100 patients with primary biliary cirrhosis. New Engl J Med 1973; 289: 674-8
4. 4 Heathcote J. New diagnostic tests and their implications in primary biliary cirrhosis and primary sclerosing cholangitis. Current Opin Gastroenterol 1995; 11: 251-7
5. 5 Fussey SPM, Guest JR, James OFW, Yeaman SJ. Identification and analysis of the major M2 autoantigens in primary biliary cirrhosis. Proc Natl Acad Sci USA 1988; 85: 8654-8
6. 6 Van de Water J, Fregeau D, Davis P, Ansari A, Danner D, Leung P, et al. Autoantibodies of primary biliary cirrhosis recognize dihydrolipoamide acetyltransferase and inhibit enzyme function. J Immunol 1988; 141: 2321-4
7. 7 Coppel RL, McNeilage LJ, Surh CD, Van De Water J, Spithill TW, Whittingham S, et al. Primary structure of the human M2 mitochondrial autoantigen of primary biliary cirrhosis: dihydrolipoamide acetyltransferase. Proc Natl Acad Sci USA 1988; 85: 7317-21
8. 8 Surh CD, Danner DJ, Ahmed A, Coppel RL, Mackay IR, Dickson R, et al. Reactivity of PBC serum with a human fetal liver cDNA clone of branched chain alpha-keto acid dehydrogenase (BCKD) dihydrolipoamide acetyltransferase, the 52kD mitochondrial autoantigen. Hepalology 1988; 9: 63-8
9. 9 Heseltine L, Turner IB, Fussey SPM. Primary biliary cirrhosis: quantitation of autoantibodies to purified mitochondrial enzymes and correlation with disease progression. Gastroenterology 1990; 99: 1786-92
10. 10 Zurgil N, Bakimer R, Kaplan M, Youinou P, Shoenfeld Y. Anti-pyruvate dehydrogenase autoantibodies in primary biliary cirrhosis. J Clin Immunol 1991; 11: 239-45
11. 11 Kisand K, Salupere V, Uibo R. Enzyme-linked immunosorbent assays for the determination of IgG, IgA and IgM autoantibodies to pyruvate dehydrogenases in primary biliary cirrhosis. J Clin Lab Res 1994; 24: 98-101
12. 12 Van de Water J, Cooper A, Surh CD, Coppel R, Danner D, Ansari A, et al. Detection of autoantibodies to recombinant mitochondrial proteins in patients with primary biliary cirrhosis. New Engl J Med 1989; 320: 1377-80
13. 13 Leung PSC, Iwayama T, Prindiville T. Use of designer recombinant mitochondrial antigens in the diagnosis of primary biliary cirrhosis. Hepatology 1992; 15: 367-72
14. 14 Omagari K, Rowley MJ, Whittingham S, Jois JA, Byron SL, Mackay IR. Autoantibodies to M2 mitochondrial autoantigens in normal human serum by immunofluorescence and novel assays. J Gastroenterol Hepatol 1996; 11: 610-6
15. 15 Uibo R, Mackay IR, Rowley M, Humphries P, Armstrong J McD, McNeilage J. Inhibition of enzyme function by human autoantibodies to an autoantigen pyruvate dehydrogenase E2: different epitope for spontaneous human and induced rabbit autoantibodies. Clin Exp Immunol 1990; 80: 19-24
16. 16 Teoh K-L, Rowley MJ, Mackay IR. An automated microassay for enzyme inhibitory effects of M2 antibodies in primary biliary cirrhosis. Liver 1991; 11: 287-91
17. 17 Teoh K-L, Rowley MJ, Zafirakis H, Dickson ER, Wiesner RH, Gerswhin ME, et al. Enzyme inhibitory autoantibodies to pyruvate dehydrogenase complex in primary biliary cirrhosis: applications of a semi-automated assay. Hepatology 1994; 20: 1220-4
18. 18 Omagari K, Rowley MJ, Jois JA, Feeney SJ, Komatsu K, Maeda T, et al. Immunoreactivity of antimitochondrial autoantibodies in Japanese patients with primary biliary cirrhosis. J Gastroenterol 1996; 31: 61-8
19. 19 Kinoshita H, Omagari K, Whittingham S, Kato Y, Ishibashi H, Sugi K, et al. Autoimmune cholangitis and primary biliary cirrhosis - an autoimmune enigma. Liver 1999; 19: 122-8
20. 20 Kaplan MM. Primary biliary cirrhosis. New Engl J Med 1996; 335: 1570-80
21. 21 Bassendine MF, Jones DEJ. Antimitochondrial and other autoantibodies in primary biliary cirrhosis. In: Krawitt EL, Wiesner RH, Nishioka M, eds. Autoimmune Liver Diseases, 2nd edn. Amsterdam: Elsevier, 1998: 287-304
22. 22 Iwayama T, Leung PST, Rowley M, Munoz S, Nishioka M, Nakagawa T, et al. Comparative immunoreactive profiles of Japanese and American patients with primary biliary cirrhosis against mitochondrial autoantigens. Int Arch Allergy Immunol 1992; 99: 28-32
23. 23 Kinoshita H, Omagari K, Matsuo I, Yamaguchi K, Ikuno N, Kohno S. Frequency of IgG, IgM and IgA class autoantibodies against 2-oxoacid dehydrogenase complex in 102 Japanese patients with primary biliary cirrhosis. Hepatology Research 1999; 15: 163-71
24. 24 Mutimer DJ, Fussey SPM, Yeaman SJ, Kelly PJ, James OFW, Bassendine MF. Frequency of IgG and IgM autoantibodies to four specific M2 mitochondrial autoantigens in primary biliary cirrhosis. Hepatology 1989; 10: 403-7
25. 25 Fregeau DR, Prindiville T, Coppel RL, Kaplan M, Dickson ER, Gerswhin ME. Inhibition of α-ketoglutarate dehydrogenase activity by a distinct population of autoantibodies recognising dihydrolipoamide succinyltransferase in primary biliary cirrhosis, Hepatalogy 1991; 11: 975-81
26. 26 Colombato LA, Alvarez F, Cote J, Huet P-M. Autoimmune cholangiopathy: the result of consecutive primary biliary cirrhosis and autoimmune hepatitis? Gastroenterology 1994; 107: 1839-43
27. 27 Heathcote J. Autoimmune cholangitis. Gut 1997; 40: 440-2
28. 28 Sherlock S. Autoimmune cholangitis: a unique entity? Proc Mayo Clinic 1998; 73: 184-90
29. 29 Homberg JC, Abuaf N, Helmy-Khalil S, Biour M, Poupon R, Islam S, et al. Drug-induced hepatitis associated with anticytoplasmic auto-antibodies. Hepatology 1985; 5: 722-7
30. 30 Metcalf JV, Mitchison HC, Palmer JM, Jones DE, Bassendine MF, James OFW. Natural history of early primary biliary cirrhosis. Lancet 1996; 348: 1399-402
31. 31 Myszor M, James OFW. The epidemiology of primary biliary cirrhosis in north-east England: an increasingly common disease. Quart J Med 1990; 75: 377-85
32. 32 Metcalf JV, Bhopal RS, Gray J, Howel D, James OFW. Incidence and prevalence of primary biliary cirrhosis in the city of Newcastle upon Tyne, England. Int J Epidemiol 1997; 26: 830-6
33. 33 Combes B. Ursodeoxycholic acid in primary biliary cirrhosis. Sem Liver Dis 1986; 17: 125-8